FNFDCM
Folger Nolan Fleming Douglas Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.92M | Sell |
62,617
-1,495
| -2% | -$189K | 0.88% | 34 |
|
|
2025
Q1 | $8.2M | Sell |
64,112
-1,148
| -2% | -$147K | 0.92% | 32 |
|
|
2024
Q4 | $8.63M | Sell |
65,260
-1,400
| -2% | -$185K | 0.9% | 32 |
|
|
2024
Q3 | $9.71M | Buy |
66,660
+308
| +0.5% | +$44.8K | 0.96% | 29 |
|
|
2024
Q2 | $9.11M | Buy |
66,352
+675
| +1% | +$92.7K | 0.93% | 30 |
|
|
2024
Q1 | $9.01M | Buy |
65,677
+291
| +0.4% | +$39.9K | 0.92% | 30 |
|
|
2023
Q4 | $8.88M | Sell |
65,386
-2,444
| -4% | -$332K | 0.97% | 26 |
|
|
2023
Q3 | $8.3M | Buy |
67,830
+663
| +1% | +$81.1K | 0.97% | 28 |
|
|
2023
Q2 | $8.53M | Buy |
67,167
+928
| +1% | +$118K | 0.93% | 29 |
|
|
2023
Q1 | $8.56M | Sell |
66,239
-601
| -0.9% | -$77.6K | 1% | 27 |
|
|
2022
Q4 | $8.82M | Sell |
66,840
-116
| -0.2% | -$15.3K | 1.06% | 31 |
|
|
2022
Q3 | $7.83M | Buy |
66,956
+507
| +0.8% | +$59.3K | 1.07% | 27 |
|
|
2022
Q2 | $7.82M | Buy |
66,449
+37
| +0.1% | +$4.35K | 1.03% | 29 |
|
|
2022
Q1 | $8.65M | Buy |
66,412
+2,590
| +4% | +$337K | 0.97% | 30 |
|
|
2021
Q4 | $9.74M | Buy |
63,822
+1,281
| +2% | +$196K | 1.06% | 26 |
|
|
2021
Q3 | $10.1M | Buy |
62,541
+1,898
| +3% | +$307K | 1.22% | 24 |
|
|
2021
Q2 | $9.92M | Buy |
60,643
+2,484
| +4% | +$406K | 1.15% | 24 |
|
|
2021
Q1 | $8.76M | Buy |
58,159
+1,726
| +3% | +$260K | 1.06% | 25 |
|
|
2020
Q4 | $8.55M | Buy |
56,433
+1,060
| +2% | +$161K | 1.13% | 23 |
|
|
2020
Q3 | $7.5M | Buy |
55,373
+2,122
| +4% | +$287K | 1.12% | 23 |
|
|
2020
Q2 | $7.28M | Sell |
53,251
-89
| -0.2% | -$12.2K | 1.18% | 23 |
|
|
2020
Q1 | $5.75M | Sell |
53,340
-1,471
| -3% | -$158K | 1.15% | 27 |
|
|
2019
Q4 | $6.61M | Buy |
54,811
+260
| +0.5% | +$31.3K | 0.96% | 33 |
|
|
2019
Q3 | $5.43M | Buy |
54,551
+825
| +2% | +$82.1K | 0.84% | 35 |
|
|
2019
Q2 | $5.86M | Buy |
53,726
+2,025
| +4% | +$221K | 0.88% | 34 |
|
|
2019
Q1 | $5.78M | Buy |
51,701
+2,380
| +5% | +$266K | 0.86% | 33 |
|
|
2018
Q4 | $4.76M | Buy |
49,321
+990
| +2% | +$95.5K | 0.78% | 35 |
|
|
2018
Q3 | $5.89M | Buy |
48,331
+1,184
| +3% | +$144K | 0.83% | 30 |
|
|
2018
Q2 | $5.18M | Buy |
47,147
+1,735
| +4% | +$191K | 0.75% | 32 |
|
|
2018
Q1 | $4.85M | Buy |
45,412
+1,455
| +3% | +$155K | 0.72% | 36 |
|
|
2017
Q4 | $4.69M | Buy |
43,957
+29,693
| +208% | +$3.17M | 0.65% | 36 |
|
|
2017
Q3 | $4.76M | Buy |
14,264
+740
| +5% | +$247K | 0.69% | 31 |
|
|
2017
Q2 | $4.19M | Buy |
13,524
+255
| +2% | +$79.1K | 0.64% | 36 |
|
|
2017
Q1 | $3.89M | Buy |
13,269
+898
| +7% | +$263K | 0.58% | 40 |
|
|
2016
Q4 | $3.58M | Hold |
12,371
| – | – | 0.59% | 40 |
|
|
2016
Q3 | $3.58M | Buy |
12,371
+7
| +0.1% | +$2.03K | 0.59% | 40 |
|
|
2016
Q2 | $3.18M | Buy |
12,364
+430
| +4% | +$111K | 0.55% | 46 |
|
|
2016
Q1 | $3.11M | Buy |
11,934
+1,428
| +14% | +$372K | 0.56% | 43 |
|
|
2015
Q4 | $3.55M | Buy |
10,506
+444
| +4% | +$150K | 0.63% | 37 |
|
|
2015
Q3 | $3.05M | Buy |
10,062
+210
| +2% | +$63.7K | 0.63% | 39 |
|
|
2015
Q2 | $3.64M | Sell |
9,852
-190
| -2% | -$70.1K | 0.67% | 35 |
|
|
2015
Q1 | $3.45M | Buy |
10,042
+105
| +1% | +$36.1K | 0.6% | 38 |
|
|
2014
Q4 | $3.01M | Buy |
9,937
+190
| +2% | +$57.6K | 0.52% | 44 |
|
|
2014
Q3 | $2.67M | Buy |
9,747
+340
| +4% | +$93K | 0.48% | 46 |
|
|
2014
Q2 | $2.42M | Buy |
9,407
+370
| +4% | +$95.1K | 0.44% | 50 |
|
|
2014
Q1 | $2.14M | Buy |
9,037
+2,350
| +35% | +$555K | 0.44% | 51 |
|
|
2013
Q4 | $1.52M | Buy |
6,687
+1,080
| +19% | +$245K | 0.27% | 64 |
|
|
2013
Q3 | $1.18M | Sell |
5,607
-190
| -3% | -$39.8K | 0.23% | 74 |
|
|
2013
Q2 | $1.01M | Buy |
+5,797
| New | +$1.01M | 0.21% | 73 |
|